Publicaciones
-
Cabana-Domínguez J, Vilar-Ribó L, Soler Artigas M, Alemany S, Llonga N, Carabí-Gassol P, Zubizarreta-Arruti U, Macias-Chimborazo V, Grau-López L, Daigre C, Ros-Cucurull E, Palma-Alvarez RF, Ortega-Hernández G, Fernandez-Castillo N, Cormand B, Ramos-Quiroga JA and Ribasés M.
Exploring the genetic overlap between substance use disorder and educational attainment
ADDICTION . : .
-
Leggieri A, García-González J, Hosseinian S, Ashdown P, Anagianni S, Wang X, Havelange W, Fernandez-Castillo N, Cormand B and Brennan CH.
rbfox1 LoF mutants show disrupted bdnf/trkb2 and crhb/nr3c2 expression and increased cortisol levels during development coupled with signs of allostatic overload in adulthood.
TRANSLATIONAL PSYCHIATRY . 15(1): 519-519.
-
Samulenaite S, García-Blanco A, Mayneris-Perxachs J, Domingo-Rodríguez L, Cabana-Domínguez J, Fernandez-Castillo N, Gago-García E, Pineda L, Burokas A, Espinosa-Carrasco J, Arboleya S, Latorre J, Stanton C, Hosomi K, Kunisawa J, Cormand B, Fernández-Real JM, Maldonado R and Martín-García E.
Gut microbiota signatures of vulnerability to food addiction in mice and humans
Gut . 73(11): 1799-1815. Nº de citas: 19
-
Leggieri A, García-González J, Hosseinian S, Ashdown P, Anagianni S, Wang X, Havelange W, Fernandez-Castillo N, Cormand B and Brennan CH.
rbfox1 loss of function in zebrafish leads to dysregulation in bdnf/trkb2 and pac1a expression resulting in HPI axis hyperactivation, altered stress response and allostatic overload.
Biorxiv . : .
-
Zillich E, Belschner H, Avetyan D, Andrade-Brito D, Martínez-Magaña JJ, Frank J, Mechawar N, Turecki G, Cabana-Domínguez J, Fernandez-Castillo N, Cormand B, Montalvo-Ortiz JL, Nöthen MM, Hansson AC, Rietschel M, Spanagel R, Witt SH and Zillich L.
Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder
TRANSLATIONAL PSYCHIATRY . 14(1): 428-428. Nº de citas: 4
-
Vilar-Ribó L, Cabana-Domínguez J, Alemany S, Llonga N, Arribas L, Grau-López L, Daigre C, Cormand B, Fernandez-Castillo N, Ramos-Quiroga JA, Soler Artigas M and Ribasés M.
Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores
TRANSLATIONAL PSYCHIATRY . 14(1): 221-221. Nº de citas: 2
-
Koller D, Mitjans M, Kouakou M, Friligkou E, Cabrera-Mendoza B, Deak JD, Llonga N, Pathak GA, Stiltner B, Løkhammer S, Levey DF, Zhou H, Hatoum AS, Kember RL, Kranzler HR, Stein MB, Corominas R, Demontis D, Artigas MS, Ramos-Quiroga JA, Gelernter J, Ribasés M, Cormand B and Polimanti R.
Genetic contribution to the comorbidity between attention-deficit/ hyperactivity disorder and substance use disorders
PSYCHIATRY RESEARCH . 333: 115758-115758. Nº de citas: 6
-
Antón-Galindo E, Adel MR, García-González J, Leggieri A, López-Blanch L, Irimia M, Norton WHJ, Brennan CH, Fernandez-Castillo N and Cormand B.
Pleiotropic contribution of rbfox1 to psychiatric and neurodevelopmental phenotypes in two zebrafish models
TRANSLATIONAL PSYCHIATRY . 14(1): 99-99. Nº de citas: 4
-
Adel MR, Antón-Galindo E, Gago-Garcia E, Arias-Dimas A, Arenas C, Artuch-Iriberri R, Cormand B and Fernandez-Castillo N.
Decreased Brain Serotonin in rbfox1 Mutant Zebrafish and Partial Reversion of Behavioural Alterations by the SSRI Fluoxetine
Pharmaceuticals . 17(2): . Nº de citas: 1
-
Antón-Galindo E, Cabana-Domínguez J, Torrico B, Corominas R, Cormand B and Fernandez-Castillo N.
The pleiotropic contribution of genes in dopaminergic and serotonergic pathways to addiction and related behavioral traits
Frontiers in Psychiatry . 14: 1293663-1293663. Nº de citas: 9
